Search

Your search keyword '"Nordstrom, Dan"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Nordstrom, Dan" Remove constraint Author: "Nordstrom, Dan"
44 results on '"Nordstrom, Dan"'

Search Results

1. Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration

2. Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries

3. Evidence-Based Practices in Mentoring Students with Disabilities: Four Case Studies

4. Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study

5. Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis : 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

6. Safety outcomes in patients with rheumatoid arthritis treated with abatacept:results from a multinational surveillance study across seven European registries

7. Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration

8. Additional file 1 of Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries

9. Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries

10. Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial

12. Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics:a Nordic population-based cohort study

13. Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study

14. Does Drug Effectiveness of 2nd and 3rd TNF Inhibitors in Patients with Psoriatic Arthritis Depend on the Reason for Withdrawal from the Previous Treatment? - Results from the EuroSpA Research Collaboration

15. Heterogeneity in the Pattern of Use of JAK-inhibitors Between Countries Participating in an International Collaboration of Registers of Rheumatoid Arthritis Patients (the JAK-pot Study)

16. TREATMENT RESPONSE AND DRUG RETENTION RATES IN 23,956 BIOLOGIC-NAIVE PATIENTS WITH AXIAL SPONDYLOARTHRITIS INITIATING TNFI TREATMENT - ROUTINE CARE DATA FROM 12 REGISTRIES IN THE EUROSPA COLLABORATION

17. DRUG RETENTION AND REMISSION RATES IN 14,261 BIOLOGIC-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS STARTING TNF INHIBITOR TREATMENT IN ROUTINE CARE - RESULTS FROM 12 REGISTRIES IN THE EUROSPA RESEARCH COLLABORATION

18. Active conventional treatment and three different biological treatments in early rheumatoid arthritis : phase IV investigator initiated, randomised, observer blinded clinical trial

19. Drug Retention and Response Rates of TNFi Treatment in 21,470 Patients with Axial Spondyloarthritis Treated in Clinical Practice-Pooled Data from the Eurospa Research Network Collaboration

21. Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study.

23. Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort

24. Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis

25. Toll-like receptors in human chondrocytes and osteoarthritic cartilage

28. Immunologic studies of nonunited fractures

30. Recruitment of Students with Disabilities: Exploration of Science, Technology, Engineering, and Mathematics.

32. Rituximab Done! What's Next in RA?

39. SEROPOSITIVITY AND RESPONSE TO RTX: DATA FROM THE CERERRA COLLABORATION

40. High Baseline Patient's Compared with Evaluator's Global Assessment Is Associated with Lower Retention and Remission Rates of First TNF Inhibitor in Psoriatic Arthritis Patients - Data from the EuroSpA Research Collaboration Network

43. Occurrence of different ensuing triggering infections preceding reactive arthritis infections preceding reactive arthritis: a follow up study .

44. Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study.

Catalog

Books, media, physical & digital resources